Filing Details
Protara Therapeutics, Inc. (NASDAQ:TARA) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 11, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:TARA
Protara Therapeutics, Inc. (TARA) Files Quarterly Report for Q0
Protara Therapeutics, Inc. (NASDAQ:TARA) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 11, 2026.
At publication ·
What changed
Protara Therapeutics, Inc. (NASDAQ:TARA) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Protara Therapeutics, Inc. (NASDAQ: TARA) filed its quarterly report (Form 10-Q) with the SEC on August 11, 2026.
- The company's stock trades at $3.91 with a market capitalization of $231.5 million.
- The 10-Q filing contains unaudited financial statements and management commentary on business performance, including updated risk factors and changes in business conditions.
Market Context
Protara Therapeutics, Inc.'s stock currently trades at $3.91 with a market capitalization of $231.5M.
The 10-Q provides Protara Therapeutics, Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Protara Therapeutics, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View TARA Stock Page
Frequently Asked Questions
Where can I read TARA's SEC filings?
Browse all filings on our TARA SEC filings page.
What types of SEC filings does Protara Therapeutics, Inc. file?
Public companies like Protara Therapeutics, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.